Share：
Share this content in WeChat
X
[Chinese][PDF]784160
• Editorial •
Molecular magnetic resonance imaging techniques: a good tool with new brightness in interpretation of life sciences
XUE Hua-dan  JIN Zheng-yu 

DOI:10.3969/j.issn.1674-8034.2011.05.001.


[Abstract] Molecular magnetic resonance imaging (mMRI) is a major method of molecular imaging for the non-invasive visualization of biological processes at the cellular and molecular level. It has been widely used in medical researches, mainly focused on facilitating the examination of cell migration, angiogenesis, apoptosis, and gene expression in in vivo. Although there are still some problems to be resolved, the unique technical advantages of mMRI will bring significant changes in clinical and basic researches.
[Keywords] Molecular magnetic resonance imaging；Molecular imaging；Molecular probe；Clinical applications

XUE Hua-dan Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China

JIN Zheng-yu* Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China

*Correspondence to: Jin ZY, E-mail: jin_zhengyu@163.com

Conflicts of interest   None.

Received  2011-08-07
Accepted  2011-09-05
DOI: 10.3969/j.issn.1674-8034.2011.05.001
DOI:10.3969/j.issn.1674-8034.2011.05.001.

[1]
Weissleder R. Molecular imaging: exploring the next frontier. Radiology, 1999, 212(3): 609-614.
[2]
Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature, 2008, 452(7187): 580-589.
[3]
任静，杨勇，王芳，等．前列腺干细胞抗原特异性MR分子探针体外成像实验研究．磁共振成像, 2010, 1(2): 138-141.
[4]
Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med, 2003, 9(1): 123-128.
[5]
Bogdanov A Jr, Matuszewski L, Bremer C, et al. Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. Mol Imaging, 2002, 1(1): 16-23
[6]
Brindle KM. Molecular imaging using magnetic resonance: new tools fort he development of tumour therapy. Br J Radiol, 2003, 76(Spec 2:): S111-S117
[7]
Herschman HR. Molecualr imaging: looking at problems seeing solutions. Science, 2003, 302(5645): 605-608
[8]
Aime S, Cabella C, Colombatto S, et al. Insights into the use of paramagnetic Gd (III) complexes in MR-molecular imaging investigations. J Magn Reson Imaging, 2002, 16(4): 394-406.
[9]
Straathof R, Strijkers GJ, Nicolay K. Target-Specific Paramagnetic and Superparamagnetic Micelles for Molecular MR Imaging. Methods Mol Biol, 2011, 771: 691-715.
[10]
Lee S, Chen X. Molecular dual-modality probes for in vivo molecular imaging. Mol Imging, 2009, 8(2): 87-100.
[11]
Jennings L, Long N. 'Two is better than one'--probes for dual-modality molecular imaging. Chem Commun (Camb), 2009, (24): 3511-3524.
[12]
Lee HY, Li Z, Chen K, et al. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J Nucl Med, 2008, 49(8): 1371-1379.
[13]
Louie AY, Huber MM, Ahrens ET, et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol, 2000, 18(3): 321-325.
[14]
van Tilborg GA, Mulder WJ, van der Schaft DW. Improved Magnetic Resonance Molecular Imaging of Tumor Angiogenesis by Avidin-Induced Clearance of Nonbound Bimodal Liposomes. Neoplasia, 2008, 10(12): 1459-1469.
[15]
Zhang C, Jugold M, Woenne EC, et al. Specific targeting of tumor angiogenesis by RGD conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Res, 2007, 67(4): 1555-1562.
[16]
Kayyem JF, Kumar RM, Fraser SE, et al. Receptor-targeted co-transport of DNA and magnetic resonance contrast agents. Chem Biol, 1995, 2(9): 615-620.
[17]
Wong FC, Kim EE. A review of molecular imaging studies reaching the clinical stage. Eur J Radiol, 2009, 70(2): 205-211.
[18]
Neri M, Maderna C, Cavazzin C, et al. Efficient in vitro labeling of human neural precursor cells with superparamagnetic iron oxide particles: relevance for in vivo cell tracking. Stem Cells, 2008, 26(2): 505-516.
[19]
Qiao H, Zhang H, Zheng Y, et al. Embryonic Stem Cell Grafting in Normal and Infarcted Myocardium: Serial Assessment with MR Imaging and PET Dual Detection. Radiology, 2009, 250(3): 821-829.
[20]
Willmann JK, van Bruggen N, Dinkelborg LM, et al. Molecular imaging in drug development. Nat Rev Drug Discov, 2008, 7(7): 591-607.
[21]
Baker M. Whole-animal imaging: The whole picture. Nature, 2010, 463(7283): 977-980.

PREV MRI analysis of a relapsing-remitting multiple sclerosis patient
NEXT Evaluation of CLT1-(Gd-DTPA) for MR molecular imaging in a mouse breast cancer model
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn